88 related articles for article (PubMed ID: 1659369)
21. Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.
Kobayashi N; Taniguchi K; Urasawa S
Arch Virol; 1991; 117(1-2):73-84. PubMed ID: 1706592
[TBL] [Abstract][Full Text] [Related]
22. Development and characterization of monoclonal antibodies to spring viraemia of carp virus.
Chen ZY; Liu H; Li ZQ; Zhang QY
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):266-76. PubMed ID: 18378003
[TBL] [Abstract][Full Text] [Related]
23. Identification of operationally overlapping and independent cross-reactive neutralization regions on human rotavirus VP4.
Kobayashi N; Taniguchi K; Urasawa S
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2615-23. PubMed ID: 1701477
[TBL] [Abstract][Full Text] [Related]
24. Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates.
Coulson BS; Fowler KJ; Bishop RF; Cotton RG
J Virol; 1985 Apr; 54(1):14-20. PubMed ID: 2579249
[TBL] [Abstract][Full Text] [Related]
25. Development of a monoclonal antibody specific for serotype 3 rotavirus strains.
Grunert B; Streckert HJ; Liedtke W; Houly C; Mietens C; Werchau H
Eur J Clin Microbiol; 1987 Apr; 6(2):136-41. PubMed ID: 3036497
[TBL] [Abstract][Full Text] [Related]
26. Neutralizing monoclonal antibodies against three serotypes of porcine rotavirus.
Nagesha HS; Brown LE; Holmes IH
J Virol; 1989 Aug; 63(8):3545-9. PubMed ID: 2545925
[TBL] [Abstract][Full Text] [Related]
27. Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3.
Coulson BS; Tursi JM; McAdam WJ; Bishop RF
Virology; 1986 Oct; 154(2):302-12. PubMed ID: 2429439
[TBL] [Abstract][Full Text] [Related]
28. Antigenic mapping of the surface proteins of rhesus rotavirus.
Shaw RD; Vo PT; Offit PA; Coulson BS; Greenberg HB
Virology; 1986 Dec; 155(2):434-51. PubMed ID: 2431540
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of rotavirus in vitro transcription by optimal concentrations of monoclonal antibodies specific for rotavirus VP6.
Ginn DI; Ward RL; Hamparian VV; Hughes JH
J Gen Virol; 1992 Nov; 73 ( Pt 11)():3017-22. PubMed ID: 1331302
[TBL] [Abstract][Full Text] [Related]
30. Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies.
Taniguchi K; Hoshino Y; Nishikawa K; Green KY; Maloy WL; Morita Y; Urasawa S; Kapikian AZ; Chanock RM; Gorziglia M
J Virol; 1988 Jun; 62(6):1870-4. PubMed ID: 2452893
[TBL] [Abstract][Full Text] [Related]
31. Reactivity of anti-human rotavirus VP4 neutralizing monoclonal antibodies with animal rotaviruses and with unusual human rotaviruses having different P and G serotypes.
Kobayashi N; Taniguchi K; Urasawa T; Urasawa S
Res Virol; 1993; 144(3):201-7. PubMed ID: 8395075
[TBL] [Abstract][Full Text] [Related]
32. Cross-neutralizing antibodies induced by single serotype vaccination of cows with rotavirus.
Brüssow H; Walther I; Fryder V; Sidoti J; Bruttin A
J Gen Virol; 1988 Jul; 69 ( Pt 7)():1647-58. PubMed ID: 2839600
[TBL] [Abstract][Full Text] [Related]
33. Serum antibody responses to individual viral polypeptides in human rotavirus infections.
Svensson L; Sheshberadaran H; Vene S; Norrby E; Grandien M; Wadell G
J Gen Virol; 1987 Mar; 68 ( Pt 3)():643-51. PubMed ID: 3029295
[TBL] [Abstract][Full Text] [Related]
34. Non-specific immunoprecipitation of rotavirus Vp6 protein with Staphylococcus aureus.
Cornaglia EM; Elazhary Y; Hamel J; Brodeur BR
FEMS Microbiol Lett; 1991 May; 64(2-3):239-42. PubMed ID: 1653168
[TBL] [Abstract][Full Text] [Related]
35. Identification of serotype 9 human rotavirus by enzyme-linked immunosorbent assay with monoclonal antibodies.
Midthun K; Valdesuso J; Kapikian AZ; Hoshino Y; Green KY
J Clin Microbiol; 1989 Sep; 27(9):2112-4. PubMed ID: 2550520
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.
Ruggeri FM; Greenberg HB
J Virol; 1991 May; 65(5):2211-9. PubMed ID: 1850007
[TBL] [Abstract][Full Text] [Related]
37. Generation and characterization of mouse monoclonal antibodies against the VP4 protein of group A human rotaviruses.
Zeng Y; Song F; Luo G; Yang H; Li C; Liu W; Li T; Zhang S; Wang Y; Huang C; Ge S; Zhang J; Xia N
Antiviral Res; 2022 Nov; 207():105407. PubMed ID: 36152816
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of anti-rotavirus immunoglobulins secreted by cloned hybridoma cell lines.
Roseto A; Scherrer R; Cohen J; Guillemin MC; Charpilienne A; Feynerol C; Peries J
J Gen Virol; 1983 Jan; 64 (Pt 1)():237-40. PubMed ID: 6296301
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of monoclonal antibodies to rotavirus.
Horng WJ; Spiezia KS; Mushahwar IK
J Virol Methods; 1989 Mar; 23(3):241-52. PubMed ID: 2469693
[TBL] [Abstract][Full Text] [Related]
40. Derivation of neutralizing monoclonal antibodies against rotavirus.
Sonza S; Breschkin AM; Holmes IH
J Virol; 1983 Mar; 45(3):1143-6. PubMed ID: 6300449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
